Literature DB >> 18230941

Increase in antidepressant medication in the US adult population between 1990 and 2003.

Ramin Mojtabai1.   

Abstract

BACKGROUND: The rate of antidepressant treatment in the US has significantly increased in the past decade. There are, however, concerns about undertreatment among traditionally underserved groups and overtreatment in less severely ill individuals. This study examines trends in the prevalence of antidepressant drug treatment in two US general population surveys.
METHODS: The prevalence of antidepressant treatment within a 12-month period was compared in the US National Comorbidity Survey (1990-1992) and the National Comorbidity Survey-Replication (2001-2003). Variations in trends across groups were examined using bivariate and multivariate logistic regression models.
RESULTS: The rate of antidepressant drug treatment increased more than four times between early 1990s and early 2000s. The trend was similar across sociodemographic groups. Younger adults, men and racial/ethnic minorities continued to receive antidepressant treatment at a lower rate compared to middle-aged adults, women and non-Hispanic whites, respectively. The rate of antidepressant treatment increased more in the group of less severely ill individuals than in those with more severe psychopathology.
CONCLUSIONS: Sociodemographic disparities in antidepressant treatment persisted over the last decade in the US, lending support to concerns about undertreatment among traditionally underserved groups, whereas the greater increase in the rate of antidepressant treatment in the less severely ill group lends support to concerns about antidepressant overtreatment in this population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18230941     DOI: 10.1159/000112885

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  25 in total

1.  Help-seeking for emotional problems in major depression : findings of the 2006 Estonian health survey.

Authors:  Anne Kleinberg; Anu Aluoja; Veiko Vasar
Journal:  Community Ment Health J       Date:  2012-02-04

2.  Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis.

Authors:  Christel Renoux; Lisa M Lix; Valérie Patenaude; Lauren C Bresee; J Michael Paterson; Jean-Philippe Lafrance; Hala Tamim; Salaheddin M Mahmud; Mhd Wasem Alsabbagh; Brenda Hemmelgarn; Colin R Dormuth; Pierre Ernst
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-31       Impact factor: 8.237

3.  Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults.

Authors:  A Pan; Q Sun; O I Okereke; K M Rexrode; R R Rubin; M Lucas; W C Willett; J E Manson; F B Hu
Journal:  Diabetologia       Date:  2011-08-03       Impact factor: 10.122

4.  Has increased provision of treatment reduced the prevalence of common mental disorders? Review of the evidence from four countries.

Authors:  Anthony F Jorm; Scott B Patten; Traolach S Brugha; Ramin Mojtabai
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

5.  Antidepressant use and glycemic control.

Authors:  Ramin Mojtabai
Journal:  Psychopharmacology (Berl)       Date:  2013-01-20       Impact factor: 4.530

6.  Selective serotonin reuptake inhibitor use and increased risk of cataract surgery: a population-based, case-control study.

Authors:  Jay C Erie; Scott M Brue; Alanna M Chamberlain; David O Hodge
Journal:  Am J Ophthalmol       Date:  2014-03-14       Impact factor: 5.258

7.  Patterns of serotonergic antidepressant usage in prodromal Huntington disease.

Authors:  Kelly C Rowe; Jane S Paulsen; Douglas R Langbehn; Chiachi Wang; James Mills; Leigh J Beglinger; Megan M Smith; Eric A Epping; Jess G Fiedorowicz; Kevin Duff; Adam Ruggle; David J Moser
Journal:  Psychiatry Res       Date:  2012-03-05       Impact factor: 3.222

8.  The Association Between Air Pollution and Onset of Depression Among Middle-Aged and Older Women.

Authors:  Marianthi-Anna Kioumourtzoglou; Melinda C Power; Jaime E Hart; Olivia I Okereke; Brent A Coull; Francine Laden; Marc G Weisskopf
Journal:  Am J Epidemiol       Date:  2017-05-01       Impact factor: 4.897

9.  Antidepressant use and lifetime history of mental disorders in a community sample: results from the Baltimore Epidemiologic Catchment Area Study.

Authors:  Yoichiro Takayanagi; Adam P Spira; O Joseph Bienvenu; Rebecca S Hock; Michelle C Carras; William W Eaton; Ramin Mojtabai
Journal:  J Clin Psychiatry       Date:  2015-01       Impact factor: 4.384

Review 10.  Antidepressants and Cdk inhibitors: releasing the brake on neurogenesis?

Authors:  Vera Chesnokova; Robert N Pechnick
Journal:  Cell Cycle       Date:  2008-06-17       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.